Evidence map›Paper›PMID 40218035›Full record

ArticleHealthcare (Basel, Switzerland)2025

Differences in Clinical, Epidemiological, and Pathological Features of Breast Cancer in the Saudi Population: An Analytical Cross-Sectional Single Institution Study.

Sajid Durrani, Saad Alamri, Sojib Bin Zaman, Yosef Alobaisi, Abdullah Bany Hamdan, Musa Alharbi, Jude Howaidi, Khalil Alamri, Filwah Almarzouq, Alaa Alyahyawi

Abstract read
In one paragraph

Article in Healthcare (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Sajid DurraniComprehensive Cancer Center, King Fahad Medical City, Riyadh 11525, Saudi Arabia.ORCID 0000-0002-6591-7341
Saad AlamriResearch Center, King Fahad Medical City, Riyadh 11525, Saudi Arabia.ORCID 0000-0002-0936-5247
Sojib Bin ZamanDepartment of Health Sciences, James Madison University, Harrisonburg, VA 22807, USA.ORCID 0000-0002-3043-7954
Yosef AlobaisiPathology and Clinical Laboratory Medicine Administration, King Fahad Medical City, Riyadh 11525, Saudi Arabia.ORCID 0009-0001-4509-5571
Abdullah Bany HamdanComprehensive Cancer Center, King Fahad Medical City, Riyadh 11525, Saudi Arabia.
Musa AlharbiComprehensive Cancer Center, King Fahad Medical City, Riyadh 11525, Saudi Arabia.
Jude HowaidiClinical Pharmacy Department, King Fahad Medical City, Riyadh 11525, Saudi Arabia.
Khalil AlamriClinical Pharmacy Department, King Fahad Medical City, Riyadh 11525, Saudi Arabia.
Filwah AlmarzouqClinical Pharmacy Department, King Fahad Medical City, Riyadh 11525, Saudi Arabia.
Alaa AlyahyawiResearch Center, King Fahad Medical City, Riyadh 11525, Saudi Arabia.

Funding

Research Center at King Fahad Medical City NA
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

biomarkerinvasive ductal carcinomaKi67 indexmolecular subtypeSaudi Arabia

Identifiers

PMID40218035
PMCPMC11988355

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.